The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis

Tuberculosis

Volumn 82, Issue 4-5, 2002, Pages 149-160

  Slayden, R A ^a   Barry III, Clifton E ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL CARRIER PROTEIN; BETA KETOACYL SYNTHASE; FATTY ACID SYNTHASE; ISONIAZID; MALONYL COENZYME A; MEROMYCOLIC ACID; MONOUNSATURATED FATTY ACID; MYCOLIC ACID; PALMITOYL COENZYME A; PROTEIN KASA; PROTEIN KASB; SYNTHETASE; THIOLACTOMYCIN; TRICLOSAN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; FATTY ACID SYNTHESIS; GENE OVEREXPRESSION; HYDROGENATION; IN VITRO STUDY; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPERON; PRIORITY JOURNAL; TUBERCULOSIS;

MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 0036448224     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1054/tube.2002.0333     Document Type: Article

References (52)

1. Barry C E, 3rd et al. Mycolic acids: Structure, biosynthesis and physiological functions. Prog Lipid Res 1998; 37: 143-179.
2. Liu J et al. Mycolic acid structure determines the fluidity of the mycobacterial cell wall. J Biol Chem 1996; 271(47): 29545-29551.
3. Slayden R A Barry C E. 3rd. The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect 2000; 6: 1-11.
4. Slayden R A, Lee R E, Barry C E. 3rd. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. Mol Microbiol 2000; 38(3): 514-525.
5. Banerjee A et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994; 263: 227-230.
6. Bardou F et al. Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins. Antimicrob Agents Chemother 1996; 40(11): 2459-2467.
7. Mdluli K et al. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science 1998; 280: 1607-1610.
8. Takayama K, Wang L, David H L. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1972; 2: 29-35.
9. Barry C E. 3rd. et al. Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs. Biochem Pharmacol 2000; 59(3): 221-231.
10. Schaeffer M L et al. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB. J Biol Chem 2001; 276(50): 47029-47037.
11. Wilson M, et al. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci USA 1999; 96: 12833-12838.
12. Cole S T, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [published erratum appears in Nature 1998; 396(6707):190]. Nature, 1998; 393(6685): 537-544.
13. Cronan J E Jr, Rock C O. Biosynthesis of membrane lipids, In: Neidhardt FC, Ed. Escherichia coli and Salmonella Cellular and Molecular Biology. Washington D.C.: ASM Press, 1996: 612-636.
14. Slabas A R et al. Pivotal reactions in fatty acid synthesis. Prog Lipid Res 1994; 33(1-2): 39-46.
15. Wakil S J, Stoops J K, Joshi V C. Fatty acid synthesis and its regulation. Annu Rev Biochem 1983; 52: 537-579.
16. Tsukamoto Y et al. The architecture of the animal fatty acid synthetase complex. IV. Mapping of active centers and model for the mechanism of action. J Biol Chem, 1983; 258(24): 15312-15322.
17. Jackowski S, John J, Cronan E, Rock C O. Lipid metabolism in prokaryotes, In: Vance D E, Vance J, Eds. Biochemistry of Lipids, Lipoproteins and Membranes. Amsterdam: Elsevier Science, 1991; pp. 43-85.
18. Bloch K. Fatty acid synthases from Mycobacterium phlei. Methods Enzymol 1975; 35: 84-90.
19. Brindley D, Matsumura S, Bloch K. Mycobacterium phlei fatty acid synthetase; a bacterial multienzyme complex. Nature 1969; 224: 666-669.
20. Bloch K, Vance D. Control mechanisms in the synthesis of saturated fatty acid. Annu Rev Biochem 1977; 46: 263-298.
21. Bloch K. Control mechanisms for fatty acid synthesis in Mycobacterium smegmatis. Adv Enzymol 1977; 45: 1-84.
22. Kikuchi S, Rainwater D L, Kolattukudy P E. Purification and characterization of an unusually large fatty acid synthase from Mycobacterium tuberculosis var. bovis BCG. Arch Biochem Biophys 1992; 295: 318-326.
23. Odriozola J M, Ramos J A, Bloch K. Fatty acid synthetase activity in Mycobacterium smegmatis. Characterization of the acyl carrier protein-dependent elongating system. Biochim Biophys Acta 1977; 488(2): 207-217.
24. Yuan Y et al. The biosynthesis of mycolic acids in Mycobacterium tuberculosis. Enzymatic methyl(ene) transfer to acyl carrier protein bound meromycolic acid in vitro. J Biol Chem 1998; 273: 21282-21290.
25. Mdluli K et al. Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol 1998; 27(6): 1223-1233.
26. Qureshi N, Sathyamoorthy N, Takayama K. Biosynthesis of C30 to C56 fatty acids by an extract of Mycobacterium tuberculosis H37Ra. J Bacteriol 1984; 157(1): 46-52.
27. Dreier J, Khosla C. Mechanistic analysis of a type II polyketide synthase. Role of conserved residues in the beta-ketoacyl synthase-chain length factor heterodimer. Biochemistry 2000; 39(8): 2088-2095.
28. Slayden R A, et al. Antimycobacterial action of thiolactomycin: An inhibitor of fatty acid and mycolic acid synthesis. Antimicrob Agents Chemother 1996; 40(12): 2813-2819.
29. Kremer L et al. Thiolactomycin and related-analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem 2000; 275(22): 16857-16864.
30. Levy C W et al. Molecular basis of triclosan activity [letter]. Nature, 1999; 398(6726): 383-384.
31. McMurry L M, Oethinger M, Levy S B. Triclosan targets lipid synthesis [letter]. Nature 1998; 394(6693): 531-532.
32. McMurry L M, McDermott P F, Levy S B. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother 1999; 43(3): 711-713.
33. Parikh S, Xiao G, Tonge P. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by Triclosan and Isoniazid. Biochemistry 2000; 39(26): 7645-7650.
34. Stewart M J et al. Structural basis and mechanism of enoyl reductase inhibition by triclosan. J Mol Biol 1999; 290(4): 859-865.
35. Ward W H et al. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Biochemistry 1999; 38(38): 12514-12525.
36. Parrish N M et al. Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis. J Antimicrob Chemother 1999; 43(2): 219-226.
37. Inokoshi J et al. Cerulenin-resistant mutants of Saccharomyces cerevisiae with an altered fatty acid synthase gene. Mol Gen Genet 1994; 244(1): 90-96.
38. Funabashi H et al. Binding site of cerulenin in fatty acid synthetase. J Biochem (Tokyo) 1989; 105(5): 751-755.
39. Omura S. Cerulenin. Methods Enzymol 1981; 72: 520-532.
40. Moche M et al. Structure of the complex between the antibiotic cerulenin and its target, beta-ketoacyl-acyl carrier protein synthase. J Biol Chem 1999; 274(10): 6031-6034.
41. Wood W I, Peterson D O, Bloch K. Subunit Structure of Mycobacterium smegmatis fatty acid synthetase. J Biol Chem 1978; 253: 2650-2656.
42. Khosla C et al. Tolerance and specificity of polyketide synthases. Annu Rev Biochem 1999; 68: 219-253.
43. Gokhale R S et al. Functional orientation of the acyltransferase domain in a module of the erythromycin polyketide synthase. Biochemistry 1998; 37(8): 2524-2528.
44. Hopwood D A. Genetic contributions to understanding polyketide synthases. Chem Rev 1997; 97: 2465-2497.
45. Besra G S et al. The synthesis of methyl 4-(2-octadecylcyclopropen-1-yl)butanoate: A possible inhibitor in mycolic acid biosynthesis. Chem Phys Lipids 1993; 66: 35-40.
46. Shimakata T, Iwaki M, Kusaka T. In vitro synthesis of mycolic acids by the fluffy layer fraction of Bacterionema matruchotii. Arch Biochem Biophys 1984; 229(1): 329-339.
47. Lacave C, Quemard A, Laneelle G. Cell-free synthesis of mycolic acids in Mycobacterium aurum: Radioactivity distribution in newly synthesized acids and presence of cell wall in the system. Biochim Biophys Acta 1990; 1045: 58-68.
48. Lacave, C., Laneelle, M.-A. and Laneelle, G. Mycolic acid synthesis by Mycobacterium aurum cell-free extracts. Biochim Biophys Acta 1990; 1042: 315-323.
49. Wheeler P R et al. Stimulation of mycolic acid biosynthesis by incorporation of cis-tetracos-5-enoic acid in a cell-wall preperation from Mycobacterium smegmatis. Biochim Biophys Acta 1993; 1167: 182-188.
50. Shimakata T, Iwaki M, Kusaka T. In vitro synthesis of mycolic acids by fluffy layer fraction of Bacterionema matruchotii. Arch Biochem Biophys 1984; 229: 329-339.
51. Salman M, Brennan P J, Lonsdale J T. Synthesis of mycolic acids of mycobacteria: An assessment of the cell-free system in light of the whole genome. Biochim Biophys Acta 1999; 1437(3): 325-332.
52. Huang W et al. Crystal structure of beta-ketoacyl-acyl carrier protein synthase II from E. coli reveals the molecular architecture of condensing enzymes. EMBO J 1998; 17(5): 1183-1191.